NOVASIGNAL CORP.

Profile

Company Names

NOVASIGNAL CORP.
NEURAL ANALYTICS, INC.

Addresses

2440 S. SEPULVEDA BLVD., LOS ANGLELES, CA 90064

2440 S. SEPULVEDA BLVD., STE. 115, LOS ANGLELES, CA 90064

2440 S. SEPULVEDA BLVD., STE 115, LOS ANGLELES, CA 90064

2127 SAWTELLE BLVD., LOS ANGLELES, CA 90025

2127 SAWTELLE BOULEVARD, LOS ANGELES, CA 90025

10880 WILSHIRE BOULEVARD, SUITE 1101, LOS ANGELES, CA 90024

604 ARIZONA AVE., SANTA MONICA, CA 90403

Phone Numbers

877-638-7251
818-317-4999
424-231-5807

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

CALIFORNIA

Total Amount Raised:

$81,833,511.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2021-08-27 
$10,263,151.00 
$15,000,000.00 
$4,736,849.00 
Equity 
7
2020-05-07 
$14,905,150.00 
$20,000,000.00 
$5,094,850.00 
Debt 
6
2019-04-22 
$24,442,944.00 
$27,924,274.00 
$3,481,330.00 
Equity 
5
2018-05-11 
$9,474,970.00 
$9,474,970.00 
$0.00 
Debt 
4
2017-03-22 
$10,149,974.00 
$24,887,500.00 
$14,737,526.00 
Equity 
3
2015-12-18 
$9,329,303.00 
$23,646,025.00 
$14,316,722.00 
Equity 
2
2014-04-11 
$3,068,019.00 
$3,068,040.00 
$21.00 
Equity 
1
2013-08-01 
$200,000.00 
$250,000.00 
$50,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEN 
 
BAKER 
DIRECTOR
DIANE 
 
BRYANT 
EXECUTIVE OFFICER, DIRECTOR
ROY 
 
DOUMANI 
DIRECTOR
AARON 
 
GREEN 
EXECUTIVE OFFICER
ROBERT 
 
HAMILTON 
EXECUTIVE OFFICER, DIRECTOR
DANIEL 
 
HANCHEY 
EXECUTIVE OFFICER, DIRECTOR
MARK 
 
HATTENDORF 
EXECUTIVE OFFICER
DONGMEI 
 
JI 
DIRECTOR
TED 
 
KOUTOUZIS 
DIRECTOR
MARK 
 
LARET 
DIRECTOR
JI 
DONG 
MEI 
DIRECTOR
LEO 
 
PETROSSIAN 
EXECUTIVE OFFICER, DIRECTOR
LEO 
 
PETROSSIAN, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
YURI 
 
PIKOVER 
DIRECTOR
STAN 
 
ROWE 
DIRECTOR
STANTON 
 
ROWE 
DIRECTOR
STANTON 
J. 
ROWE 
DIRECTOR
JEREMY 
 
SOHN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-27 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-07 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-22 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-11 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-22 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-18 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-11 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-11 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-11 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-08-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#